CT Kapital OÜ
Acquisition of majority share in biotech company
Concluso
- Chiusura raccolta14.04.2017
- Inizio del periodo di investimento13.04.2017
- Ora di inizio07.04.2017 07:00
- Categoria di immobileM&A
- Tipo di investmentoAltro
- Data di fine dell'investimento12.04.2019
- Orizzonte d'investimento restanteRitardo oltre i 90
- Rendimento annuo15.8%
- Rendimento in contanti atteso%
- N. di investitori502
- Obiettivo€450 000
Progetto in sintesi
CT Kapital OÜ is a SPV established for the acquisiton of majority share in biotechnology company Cellin Technologies OÜ. The acquisition is to be financed with a 150,000 euros of owner's equity and a 450,000 euro crowdfunded loan facility.
The crowdfunded capital layer is structured as secured 2-year loan with a fixed annual interest rate of 15% . The loan pays quarterly interest and returns principal proportionally on 12th, 18th and 24th month.
Investment's IRR is 15.8%.